Vivesto AB reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported net loss was SEK 30.03 million compared to SEK 2.85 million a year ago. Basic loss per share from continuing operations was SEK 0.06 compared to SEK 0.01 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3 SEK | -2.76% | +2.21% | -26.38% |
Mar. 26 | Transcript : Vivesto AB - Special Call | |
Mar. 07 | Vivesto AB Doses First Patient in its Clinical Paccal Vet Trial | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.38% | 15.31M | |
+31.06% | 682B | |
+30.35% | 586B | |
-3.42% | 364B | |
+18.02% | 327B | |
+4.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.12% | 165B |
- Stock Market
- Equities
- VIVE Stock
- News Vivesto AB
- Vivesto AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022